Matthew Chivvis and Chelsea Kehrer authored an article for the Daily Journal discussing Patent Trial and Appeal Board (PTAB) proceedings in the life sciences context.
Matthew Chivvis spoke to Bloomberg Law about a congressional push to let drug companies patent diagnostic tests and other biotech invention, which is rekindling a decade-old battle.
/PRNewswire/ A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co. LTD, for.